代用合成血液と血液製剤の世界市場レポート 2025年

代用合成血液と血液製剤市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は15.9％で、137億6,000万米ドルに成長します。予測期間中に予想される成長は、軍事および災害対応における代用合成血液の使用拡大、代替血液製剤に対する意識の高まり、血液関連疾患の有病率の上昇、外傷および緊急手術の発生率の増加に起因しています。この期間に予想される主な動向には、ヘモグロビンベースの酸素キャリアの開発、規制当局の承認と進行中の研究、バイオテクノロジーの進歩、再生医療の進展、血液製剤開発における人工知能（AI）の統合などがあります。

慢性疾患の有病率の増加は、今後数年間の代用合成血液と血液製剤市場の成長を促進すると予想されます。慢性疾患は、継続的な医学的注意を必要とする長期的な状態であり、多くの場合、管理することはできるが、治癒することはできないです。高齢化、不健康なライフスタイル、平均寿命の伸びなど、これらの疾患の有病率上昇にはいくつかの要因があります。代用合成血液と血液製剤は、罹患患者によく見られる出血、貧血、臓器機能に関する課題に対処することで、慢性疾患の管理に重要な役割を果たします。例えば、2024年6月、オーストラリア保健福祉研究所は、オーストラリアにおける慢性疾患による死亡者数が、2021年の人口10万人当たり459人から2022年には490人に増加したと報告しました。このような慢性疾患による負担の増大が、代用合成血液と血液製剤の需要を牽引しています。

代用合成血液と血液製剤市場の各社は、救急医療の向上、外傷治療の強化、ドナー血液・組織の不足に対処するため、実験室で培養した血管などのイノベーションに注力しています。ヒトまたは合成細胞から工学的に作製されたラボグロウン血管は、天然の動脈や静脈の構造や機能を模倣しており、外傷の修復、透析、心臓血管外科などの用途に利用価値があります。例えば、米国を拠点とする臨床段階のバイオテクノロジー企業であるヒューマサイト・世界社は、2024年12月、緊急の血行再建術を必要とする外傷患者向けに設計された既製の生体工学的血管インプラントであるシンベスのFDA承認を取得しました。シンベスは、従来の静脈採取や合成グラフトに代わる安全な選択肢を提供し、重傷を負った後の血流を回復させ、手足を温存します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界代用合成血液と血液製剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の代用合成血液と血液製剤市場：成長率分析
• 世界の代用合成血液と血液製剤市場の実績：規模と成長, 2019-2024
• 世界の代用合成血液と血液製剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界代用合成血液と血液製剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の代用合成血液と血液製剤市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• パーフルオロカーボン系製品（PFC）
• ヘモグロビンベースの酸素キャリア
• 合成血小板
• 組み換え因子
• 血液増量剤
• 世界の代用合成血液と血液製剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心血管疾患
• 貧血
• 臓器移植
• 怪我と外傷
• その他の用途
• 世界の代用合成血液と血液製剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 血液銀行
• その他のエンドユーザー
• 世界の代用合成血液と血液製剤市場、パーフルオロカーボン系製品（PFC）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• エマルジョンベースの製品
• 非乳化ベース製品
• 世界の代用合成血液と血液製剤市場ヘモグロビンベースの酸素キャリアのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 重合ヘモグロビンベース製品
• 架橋ヘモグロビンベース製品
• 世界の代用合成血液と血液製剤市場合成血小板の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血小板代替物
• 血小板凝集阻害剤
• 世界の代用合成血液と血液製剤市場組換え因子のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組換え因子VIII
• 組換え第IX因子
• その他の組み換え因子
• 世界の代用合成血液と血液製剤市場、血液増量剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• コロイド溶液
• 晶質溶液

第7章 地域別・国別分析

• 世界の代用合成血液と血液製剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の代用合成血液と血液製剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 代用合成血液と血液製剤市場：競合情勢
• 代用合成血液と血液製剤市場：企業プロファイル
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Octapharma AG Overview, Products and Services, Strategy and Financial Analysis
  • Green Cross Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Alliance Pharmaceutical Corporation
• Hemosol Inc.
• Sanguine Corporation
• Sangart Inc.
• Biopure Corporation
• Tenex Therapeutics
• Velico Medical
• Hemarina S.A.
• KaloCyte Inc.
• Aurum Biosciences Limited
• SpheriTech Limited
• Dendritech Inc.
• HbO2 Therapeutics LLC
• HemoBioTech Inc.
• Somatogen Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 代用合成血液と血液製剤市場2029：新たな機会を提供する国
• 代用合成血液と血液製剤市場2029：新たな機会を提供するセグメント
• 代用合成血液と血液製剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Synthetic blood substitutes and blood products are innovative medical solutions designed to replicate the functions of human blood, such as oxygen transport and clotting, to assist patients in need of blood transfusions. Developed through biotechnological processes, these products play a vital role in addressing blood shortages and offering alternatives for emergencies or individuals with specific medical conditions.

The primary categories of synthetic blood substitutes and blood products include perfluorocarbon-based products (PFCs), hemoglobin-based oxygen carriers, synthetic platelets, recombinant factors, and blood expanders. Perfluorocarbon-based products (PFCs) function as synthetic oxygen carriers capable of dissolving and transporting oxygen and carbon dioxide within the bloodstream, serving as blood substitutes in medical treatments. These products are utilized for various purposes, including the treatment of cardiovascular diseases, anemia, organ transplants, injuries, and trauma. Additionally, they are used by multiple end users, such as hospitals and clinics, blood banks, and other medical institutions.

The synthetic blood substitutes and blood products market research report is one of a series of new reports from The Business Research Company that provides synthetic blood substitutes and blood products market statistics, including the synthetic blood substitutes and blood products industry global market size, regional shares, competitors with the synthetic blood substitutes and blood products market share, detailed synthetic blood substitutes and blood products market segments, market trends, and opportunities, and any further data you may need to thrive in the synthetic blood substitutes and blood products industry. This synthetic blood substitutes and blood products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The synthetic blood substitutes and blood products market size has grown rapidly in recent years. It will grow from $6.55 billion in 2024 to $7.62 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth during the historic period can be attributed to factors such as an aging population, a rising demand for blood transfusions, an increasing need for safe and contaminant-free blood, greater awareness of the risks associated with blood transfusions, and a heightened focus on emergency medical care.

The synthetic blood substitutes and blood products market size is expected to see rapid growth in the next few years. It will grow to $13.76 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The anticipated growth in the forecast period can be attributed to the expanding use of synthetic blood substitutes in military and disaster response, increasing awareness of alternative blood products, the rising prevalence of blood-related disorders, and a growing incidence of trauma and emergency surgeries. Key trends expected during this period include the development of hemoglobin-based oxygen carriers, regulatory approvals and ongoing research, advancements in biotechnology, progress in regenerative medicine, and the integration of artificial intelligence (AI) in blood product development.

The increasing prevalence of chronic diseases is expected to drive the growth of the synthetic blood substitutes and blood products market in the coming years. Chronic diseases are long-term conditions that require ongoing medical attention and can often be managed but not cured. Several factors contribute to the rising prevalence of these conditions, including an aging population, unhealthy lifestyles, and increased life expectancy. Synthetic blood substitutes and blood products play a crucial role in managing chronic diseases by addressing challenges related to blood loss, anemia, and organ function, which are common among affected patients. For example, in June 2024, the Australian Institute of Health and Welfare reported that deaths due to chronic conditions in Australia increased from 459 deaths per 100,000 population in 2021 to 490 in 2022. This growing burden of chronic diseases is driving the demand for synthetic blood substitutes and blood products.

Companies in the synthetic blood substitutes and blood products market are focusing on innovations such as lab-grown blood vessels to improve emergency medical care, enhance trauma treatment, and address shortages of donor blood and tissues. Lab-grown blood vessels, engineered from human or synthetic cells, mimic the structure and function of natural arteries and veins, making them valuable for applications such as trauma repair, dialysis, and cardiovascular surgery. For instance, in December 2024, Humacyte Global, Inc., a US-based clinical-stage biotechnology company, received FDA approval for Symvess, an off-the-shelf bioengineered blood vessel implant designed for trauma patients requiring urgent revascularization. Symvess offers a safer alternative to traditional vein harvesting or synthetic grafts, restoring blood flow and preserving limbs after severe injuries.

In December 2024, GVS S.p.A., an Italy-based plastic fabrication company, acquired blood-related assets from Haemonetics Corporation for $67.1 million. This acquisition strengthens GVS's focus on plasma and hospital-based blood management solutions while expanding its product offerings in the blood collection and filtration market. Haemonetics Corporation, a US-based company, specializes in developing and selling blood management devices, including artificial blood substitutes and other blood-related products.

Major players in the synthetic blood substitutes and blood products market are Takeda Pharmaceutical Company Limited, Fresenius Kabi AG, Baxter International Inc., Octapharma AG, Green Cross Corporation, Alliance Pharmaceutical Corporation, Hemosol Inc., Sanguine Corporation, Sangart Inc., Biopure Corporation, Tenex Therapeutics, Velico Medical, Hemarina S.A., KaloCyte Inc., Aurum Biosciences Limited, SpheriTech Limited, Dendritech Inc., HbO2 Therapeutics LLC, HemoBioTech Inc., Somatogen Inc.

North America was the largest region in the synthetic blood substitutes and blood products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in synthetic blood substitutes and blood products report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the synthetic blood substitutes and blood products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The synthetic blood substitutes and blood products market consists of sales of artificial blood substitutes, blood plasma substitutes, and blood plasma products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Synthetic Blood Substitutes And Blood Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on synthetic blood substitutes and blood products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for synthetic blood substitutes and blood products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The synthetic blood substitutes and blood products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Perfluorocarbon Based Product (PFC); Haemoglobin Based Oxygen Carrier; Synthetic Platelet; Recombinant Factor; Blood Expander
• 2) By Application: Cardiovascular Diseases; Anaemia; Organ Transplant; Injury and Trauma; Other Applications
• 3) By End-User: Hospitals And Clinics; Blood Banks; Other End users
• Subsegments:
• 1) By Perfluorocarbon Based Product (PFC): Emulsion-Based Products; Non-Emulsion-Based Products
• 2) By Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products; Crosslinked Hemoglobin-Based Products
• 3) By Synthetic Platelet: Platelet Substitutes; Platelet Aggregation Inhibitors
• 4) By Recombinant Factor: Recombinant Factor VIII; Recombinant Factor IX; Other Recombinant Factors
• 5) By Blood Expander: Colloid Solutions; Crystalloid Solutions
• Companies Mentioned: Takeda Pharmaceutical Company Limited; Fresenius Kabi AG; Baxter International Inc.; Octapharma AG; Green Cross Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Synthetic Blood Substitutes And Blood Products Market Characteristics

3. Synthetic Blood Substitutes And Blood Products Market Trends And Strategies

4. Synthetic Blood Substitutes And Blood Products Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Synthetic Blood Substitutes And Blood Products Growth Analysis And Strategic Analysis Framework

• 5.1. Global Synthetic Blood Substitutes And Blood Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Synthetic Blood Substitutes And Blood Products Market Growth Rate Analysis
• 5.4. Global Synthetic Blood Substitutes And Blood Products Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Synthetic Blood Substitutes And Blood Products Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Synthetic Blood Substitutes And Blood Products Total Addressable Market (TAM)

6. Synthetic Blood Substitutes And Blood Products Market Segmentation

• 6.1. Global Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Perfluorocarbon Based Product (PFC)
• Haemoglobin Based Oxygen Carrier
• Synthetic Platelet
• Recombinant Factor
• Blood Expander
• 6.2. Global Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Anaemia
• Organ Transplant
• Injury and Trauma
• Other Applications
• 6.3. Global Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Blood Banks
• Other End users
• 6.4. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Perfluorocarbon Based Product (PFC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Emulsion-Based Products
• Non-Emulsion-Based Products
• 6.5. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Haemoglobin Based Oxygen Carrier, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerized Hemoglobin-Based Products
• Crosslinked Hemoglobin-Based Products
• 6.6. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Synthetic Platelet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Platelet Substitutes
• Platelet Aggregation Inhibitors
• 6.7. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Recombinant Factor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Factor VIII
• Recombinant Factor IX
• Other Recombinant Factors
• 6.8. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Blood Expander, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Colloid Solutions
• Crystalloid Solutions

7. Synthetic Blood Substitutes And Blood Products Market Regional And Country Analysis

• 7.1. Global Synthetic Blood Substitutes And Blood Products Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Synthetic Blood Substitutes And Blood Products Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market

• 8.1. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Synthetic Blood Substitutes And Blood Products Market

• 9.1. China Synthetic Blood Substitutes And Blood Products Market Overview
• 9.2. China Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Synthetic Blood Substitutes And Blood Products Market

• 10.1. India Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Synthetic Blood Substitutes And Blood Products Market

• 11.1. Japan Synthetic Blood Substitutes And Blood Products Market Overview
• 11.2. Japan Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Synthetic Blood Substitutes And Blood Products Market

• 12.1. Australia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Synthetic Blood Substitutes And Blood Products Market

• 13.1. Indonesia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Synthetic Blood Substitutes And Blood Products Market

• 14.1. South Korea Synthetic Blood Substitutes And Blood Products Market Overview
• 14.2. South Korea Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Synthetic Blood Substitutes And Blood Products Market

• 15.1. Western Europe Synthetic Blood Substitutes And Blood Products Market Overview
• 15.2. Western Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Synthetic Blood Substitutes And Blood Products Market

• 16.1. UK Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Synthetic Blood Substitutes And Blood Products Market

• 17.1. Germany Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Synthetic Blood Substitutes And Blood Products Market

• 18.1. France Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Synthetic Blood Substitutes And Blood Products Market

• 19.1. Italy Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Synthetic Blood Substitutes And Blood Products Market

• 20.1. Spain Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Synthetic Blood Substitutes And Blood Products Market

• 21.1. Eastern Europe Synthetic Blood Substitutes And Blood Products Market Overview
• 21.2. Eastern Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Synthetic Blood Substitutes And Blood Products Market

• 22.1. Russia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Synthetic Blood Substitutes And Blood Products Market

• 23.1. North America Synthetic Blood Substitutes And Blood Products Market Overview
• 23.2. North America Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Synthetic Blood Substitutes And Blood Products Market

• 24.1. USA Synthetic Blood Substitutes And Blood Products Market Overview
• 24.2. USA Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Synthetic Blood Substitutes And Blood Products Market

• 25.1. Canada Synthetic Blood Substitutes And Blood Products Market Overview
• 25.2. Canada Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Synthetic Blood Substitutes And Blood Products Market

• 26.1. South America Synthetic Blood Substitutes And Blood Products Market Overview
• 26.2. South America Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Synthetic Blood Substitutes And Blood Products Market

• 27.1. Brazil Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Synthetic Blood Substitutes And Blood Products Market

• 28.1. Middle East Synthetic Blood Substitutes And Blood Products Market Overview
• 28.2. Middle East Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Synthetic Blood Substitutes And Blood Products Market

• 29.1. Africa Synthetic Blood Substitutes And Blood Products Market Overview
• 29.2. Africa Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Synthetic Blood Substitutes And Blood Products Market Competitive Landscape And Company Profiles

• 30.1. Synthetic Blood Substitutes And Blood Products Market Competitive Landscape
• 30.2. Synthetic Blood Substitutes And Blood Products Market Company Profiles
  • 30.2.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Octapharma AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Green Cross Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Synthetic Blood Substitutes And Blood Products Market Other Major And Innovative Companies

• 31.1. Alliance Pharmaceutical Corporation
• 31.2. Hemosol Inc.
• 31.3. Sanguine Corporation
• 31.4. Sangart Inc.
• 31.5. Biopure Corporation
• 31.6. Tenex Therapeutics
• 31.7. Velico Medical
• 31.8. Hemarina S.A.
• 31.9. KaloCyte Inc.
• 31.10. Aurum Biosciences Limited
• 31.11. SpheriTech Limited
• 31.12. Dendritech Inc.
• 31.13. HbO2 Therapeutics LLC
• 31.14. HemoBioTech Inc.
• 31.15. Somatogen Inc.

32. Global Synthetic Blood Substitutes And Blood Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Synthetic Blood Substitutes And Blood Products Market

34. Recent Developments In The Synthetic Blood Substitutes And Blood Products Market

35. Synthetic Blood Substitutes And Blood Products Market High Potential Countries, Segments and Strategies

• 35.1 Synthetic Blood Substitutes And Blood Products Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Synthetic Blood Substitutes And Blood Products Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Synthetic Blood Substitutes And Blood Products Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer